In summary, high expression of SOAT1 and SLC40A1 can reduce the level of lipid peroxidation, thereby reducing the conversion of cholesterol to cholesterol esters and inhibiting ferroptosis in glioma cells. Here, SLC40A1 is linked to central nervous system cancer.